Computer Stop Order Alert to Prevent Concurrent Prescribing of Trimethoprim/Sulfamethoxazole and Warfarin
NCT00870298 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1971
Last updated 2015-12-09
Summary
To determine if a computerized stop order will reduce the number of concurrent trimethoprim/sulfamethoxazole and warfarin orders accepted through the inpatient electronic ordering system while a patient is hospitalized.
Conditions
- Prescribers' Drug Orders
Interventions
- DRUG
-
Trimethoprim/Sulfamethoxazole and Warfarin
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-08-31
- Primary Completion
- 2007-01-31
- Completion
- 2007-01-31
More Related Trials
-
Prospective Evaluation of Bleeding Risk of Anticoagulant and Anti-platelet Therapy
NCT00625248 ·Status: COMPLETED
-
Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients
NCT05926518 ·Status: COMPLETED
-
Implementation of Onsite Rapid CYP2C19 Assay for Genotype Guided Dual Antiplatelet Therapy After Acute Ischemic Stroke
NCT06292117 ·Status: RECRUITING
-
DOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort Study
NCT06884384 ·Status: NOT_YET_RECRUITING
-
Efficacy of Aspirin in Preventing Venous Thromboembolism
NCT06635317 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Clarithromycin on the Pharmacokinetics of Apixaban in Healthy Participants
NCT02912234 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of International Normalized Ratio (INR) Prolongation in Patients Treated Simultaneously With Warfarin and Cephalosporins
NCT01857050 ·Status: COMPLETED
-
A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Following a Blood Clot
NCT03521908 ·Status: COMPLETED
-
Evaluation of Thromboprophylaxis Appropriateness in Hospitalized Medical Patients
NCT05449808 ·Status: UNKNOWN
-
Prevention of Cefoperazone-induced Coagulopathy
NCT05742295 ·Status: COMPLETED ·Phase: PHASE4
-
Short vs Long Duration Dual Antiplatelet Therapy in Patients Undergoing Lower Extremity Endovascular Revascularization
NCT02433587 ·Status: WITHDRAWN ·Phase: PHASE3
-
Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets
NCT05627375 ·Status: RECRUITING ·Phase: PHASE3
-
Safety Study of Vitamin K2 During Anticoagulation in Human Volunteers
NCT00512928 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of Intravenous JNJ-64179375 Versus Oral Apixaban in Participants Undergoing Elective Total Knee Replacement Surgery
NCT03251482 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Compare Pharmacokinetics & Pharmacodynamics of Warfarin & Esmolol in the Absence & Presence of MEDI0382
NCT03347968 ·Status: COMPLETED ·Phase: PHASE1
-
Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis
NCT02285738 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Comparing Different Routes and Doses of Phytonadione (Vitamin K) for Reversing Warfarin Treated Patients With Hip Fracture Before Surgery
NCT00905229 ·Status: WITHDRAWN ·Phase: NA
-
Effectiveness of Blood Clot Medication With Concomitant Blood Pressure Medication
NCT00424281 ·Status: UNKNOWN
-
The Safety of Non-vitamin K Oral Anticoagulants Compared to Warfarin Early After Cardiac Surgery
NCT05006287 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Rivaroxaban in Thrombotic Antiphospholipid Syndrome
NCT02157272 ·Status: TERMINATED ·Phase: PHASE3
-
Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT
NCT00428129 ·Status: TERMINATED ·Phase: PHASE2
-
Enhancing the Safety of Warfarin in Nursing Homes
NCT00682773 ·Status: COMPLETED ·Phase: NA
-
Delivery and Implementation of a Randomised Crossover Trial on Thrombosis
NCT06937372 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparative Study Between Thrombosis Prophylaxis Protocols
NCT00713973 ·Status: COMPLETED
-
Aspirin and Enoxaparin for VTE in Trauma
NCT02396732 ·Status: TERMINATED ·Phase: PHASE4